Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Search by expertise, name or affiliation
Meta-analysis: Terlipressin therapy for the hepatorenal syndrome
F. Fabrizi, V. Dixit, P. Martin
Dentistry
Icahn School of Medicine at Mount Sinai
Research output
:
Contribution to journal
›
Article
›
peer-review
105
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Meta-analysis: Terlipressin therapy for the hepatorenal syndrome'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Meta-analysis
100%
Hepatorenal Syndrome
100%
Terlipressin
100%
Clinical Trials
15%
Dropout
15%
Randomized Controlled Trial
7%
Systematic Literature Review
7%
Mortality Rate
7%
Random Effects Model
7%
Sensitivity Analysis
7%
Tolerability
7%
End-stage Liver Disease
7%
Lairds
7%
Vasopressin Analogues
7%
Heterogeneity Analysis
7%
Predictive Factors of Response
7%
Pharmacology, Toxicology and Pharmaceutical Science
Hepatorenal Syndrome
100%
Terlipressin
100%
Clinical Trial
15%
Recurrent Disease
15%
Randomized Controlled Trial
7%
Side Effect
7%
Tolerability
7%
Mortality Rate
7%
Random Effects Model
7%
End Stage Liver Disease
7%
Vasopressin Analogue
7%
Vasopressin
7%